CFRA Keeps Sell Opinion On Shares Of Comerica Incorporated

CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We decrease our 12-month target price by $3 to $35, 5.8x our 2024 EPS estimate, a discount to CMA’s five-year forward P/E average of 11.5x given elevated funding pressure. We increase our 2023 EPS estimate by $0.16 to $7.79 and lower 2024’s by $0.09 to $6.02. CMA posted Q3 EPS of $1.84 versus $2.60 a year ago, $0.14 above consensus. Net interest income fell 3% Q/Q as the bank’s net interest margin compressed 9 bps to 2.84%. After six straight quarters of sequential deposit outflows, balances rebounded with 2% Q/Q growth. However, noninterest-bearing balances fell 5% and we expect continued pressure as clients continue to search for yield in today’s high-rate environment. Credit quality continued to impress with nonperforming assets falling 4 bps to 0.29%. Capital levels are also strong with the bank’s CET1 ratio rising 50 bps to 10.8%. However, rising rates drove CMA’s securities portfolio deeper underwater, creating further headwinds to CMA’s earnings capacity.

Scroll to Top